Clinical Trial Update: Efficacy, Safety and Tolerability of Balcinrenone/Dapagliflozin Compared to Dapagliflozin in Adults With Chronic Kidney Disease [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Balcinrenone in combination with Dapagliflozin versus Dapagliflozin alone in adults with chronic kidney disease, focusing on efficacy, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• Balcinrenone
• Dapagliflozin (dapagliflozin)

Snippet

Sponsor: AstraZeneca | Conditions: Chronic Kidney Disease | Phase 2 | Status: COMPLETED